Art

J-GLOBAL ID：201602281147739635   Reference number：16A1276625

Effect of Switching from Sulphonylurea to Repaglinide Twice or Three Times Daily for 4 Months on Glycemic Control in Japanese Patients with Type 2 Diabetes

2型糖尿病の日本人患者における血糖管理に対するスルホニル尿素から1日2回または3回で4か月間のレパグリニドへの切り替えの効果

Author (8)： Kamiyama Hiroshi (Department of Endocrinology and Metabolism, Yokohama City University Graduate School of Medicine, Japan) ,  Aoki Kazutaka (Department of Endocrinology and Metabolism, Yokohama City University Graduate School of Medicine, Japan) ,  Aoki Kazutaka (Department of Biostatistics, Yokohama City University Hospital, Japan) ,  Nakajima Shigeru (Nakajima Naika Clinic, Japan) ,  Shinoda Kazuaki (Nakajima Naika Clinic, Japan) ,  Kamiko Kazunari (Department of Endocrinology and Metabolism, Yokohama City University Graduate School of Medicine, Japan) ,  Taguri Masataka (Department of Biostatistics, Yokohama City University Hospital, Japan) ,  Terauchi Yasuo (Department of Endocrinology and Metabolism, Yokohama City University Graduate School of Medicine, Japan)
Material： Internal Medicine (Web)  (Intern Med (Web))
Volume： 55  Issue： 13  Page： 1697-1703(J-STAGE)  Publication year： 2016 
JST Material Number： U0033A  ISSN： 1349-7235  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： sulphonylurea agent ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A1276625&from=J-GLOBAL&jstjournalNo=U0033A") }}

Author keywords (4)： repaglinide ,  sulfonylurea ,  type 2 diabetes ,  drug adherence

JST classification (1)： Treatment for metabolic diseases,nutritional diseases.  (GD05030F)

Substance index (1)： Repaglinide

Reference (24)：

• 1. Nakagami T; DECODA Study Group. Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia 47: 385-394, 2004.
• 2. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28: 103-117, 1995.
• 3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853, 1998.
• 4. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 26: 881-885, 2003.
• 5. Kikuchi K, Nezu U, Inazumi K, et al. Correlations of fasting and postprandial blood glucose increments to the overall diurnal hyperglycemic status in type 2 diabetic patients variations with levels of HbA1c. Endocr J 57: 259-266, 2010.

Terms in the title (7)： 2型糖尿病 ,  日本人 ,  患者 ,  血糖管理 ,  スルホニル尿素 ,  レパグリニド ,  切り替え